Consistent with our observation, miR‐1 was reported to correlate with advanced clinical stage in esophageal squamous cell carcinoma and served as a tumor suppressor by targeting LASP1 and TAGLN2 30, 31. This evidence concerns the gene TAGLN2 and neoplasm.